Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metolazone measurement |
Component |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone adverse reaction (disorder) |
Causative agent (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to metolazone (finding) |
Causative agent (attribute) |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metolazone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metolazone 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metolazone 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to metolazone (finding) |
Causative agent (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of prophylactic metolazone (procedure) |
Direct substance |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metolazone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone 2.5 mg oral tablet |
Has precise active ingredient |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metolazone 5 mg oral tablet |
Has precise active ingredient |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metolazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metolazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metolazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of prophylactic metolazone (procedure) |
Direct substance |
True |
Metolazone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |